Views & Analysis | Perspectives on pharma industry issues

Digital

pharmaphorum podcast Episode 284, Mati Gill, AION Labs

AI, start-ups, and the future of human health: AION Labs’ Ma...

In a new episode of the pharmaphorum podcast, Nicole Raleigh invites Mati Gill, CEO of AION Labs, back as guest.

R&D

Auto vacuum sealed vaccines in manufacturing plant

Reliability in life sciences logistics: What good looks like

What constitutes a reliable supply chain is changing rapidly.

Oncology

How AI is advancing patient subgroup identification in oncol...

With the advent of AI, it’s now possible to enrich clinical trials for patient subgroups more precisely than ever before.

Oncology

Personal reflections on World ADC, San Diego

At World ADC this month, the latest advances in ADC discovery and development were presented, debated, and reflected upon.

Oncology

ESMO26: Taiho Oncology on improving the lives of patients wi...

Dr Harold Keer, chief medical officer at Taiho Oncology, discusses the Phase 2 REZILIENT2 trial data presented at ESMO26 and the NSCLC setting.

Articles

Biosimilars and biobetters: what is the market waiting for?

This interview with Dr Conrad Savoy explores the challenges involved with getting biosimilars and biobetters to market. Biosimilars and biobetters present a lucrative opportunity to benefit from patent expirations on biologicals, however entering the biosimilars…

Articles

mHealth Monthly Mashup: release 15.0 – how Nike fuel band pa...

This month’s mashup provides a tantalizing case study that points to the future of mobile health… Mobile is the uncontested technological and communications channel of the millennium, and health is a two trillion dollar per annum…

Articles

Pharma global manufacturing: improving environment in the UK

Rebecca Aris provides an update on global pharmaceutical manufacturing in the UK following the recent announcement by Eisai to transfer global manufacturing of its new epilepsy medicine to the UK. It came as a huge shock when, in 2011, Pfizer announced that it was to close its UK research site at Sandwich in Kent. The move...

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

AI, start-ups, and the future of human health: AION Labs’ Ma...

In a new episode of the pharmaphorum podcast, Nicole Raleigh invites Mati Gill, CEO of AION Labs, back as guest.

Digital

A sponsored video interview with Axria's Jeff Kaminski

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.